Steel Peak Wealth Management »

Crispr Therapeutics shares owned by Steel Peak Wealth Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Steel Peak Wealth Management from 13F filings

Historical chart of Steel Peak Wealth Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Steel Peak Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Steel Peak Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $478k 10k 46.98
2024-06-30 $846k 16k 54.01
2024-03-31 $699k 10k 68.16
2023-12-31 $280k 4.5k 62.60
2023-09-30 $262k 5.8k 45.39
2023-06-30 $283k 5.0k 56.14
2023-03-31 $426k 9.4k 45.23
2022-12-31 $272k 6.7k 40.65
2022-09-30 $390k 6.0k 65.28
2022-06-30 $443k 7.3k 60.78
2022-03-31 $867k 14k 62.81
2021-12-31 $890k 12k 75.76
2021-09-30 $701k 6.3k 112.00
2021-06-30 $602k 3.7k 162.00
2021-03-31 $318k 2.6k 121.79